Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2011, Article ID 917015, 11 pages
http://dx.doi.org/10.1155/2011/917015
Research Article

Suppressors of Cytokine Signaling 3 Expression in Eosinophils: Regulation by PGE2 and Th2 Cytokines

1Immunology Department, IIS-Fundación Jiménez Díaz (IIS-FJD), Avenida Reyes Católicos 2, 28040 Madrid, Spain
2CIBER of Respiratory Diseases (CIBERES) ISCII, Madrid, Spain
3Allergy Department, IIS-Fundación Jiménez Díaz (IIS-FJD), 28040 Madrid, Spain
4Allergy Department, Hospital Universitario La Paz, Madrid, Spain

Received 16 November 2010; Revised 2 March 2011; Accepted 17 March 2011

Academic Editor: Hiroshi Nakajima

Copyright © 2011 Esther López et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. G. Gibson, J. Dolovich, J. Denburg, E. H. Ramsdale, and F. E. Hargreave, “Chronic cough: eosinophilic bronchitis without asthma,” Lancet, vol. 1, no. 8651, pp. 1346–1348, 1989. View at Google Scholar · View at Scopus
  2. C. E. Brightling, R. Ward, K. L. Goh, A. J. Wardlaw, and I. D. Pavord, “Eosinophilic bronchitis is an important cause of chronic cough,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 2, pp. 406–410, 1999. View at Google Scholar · View at Scopus
  3. C. E. Brightling, F. A. Symon, S. S. Birring, P. Bradding, I. D. Pavord, and A. J. Wardlaw, “TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis,” Journal of Allergy and Clinical Immunology, vol. 110, no. 6, pp. 899–905, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. C. E. Brightling, F. A. Symon, S. S. Birring, P. Bradding, A. J. Wardlaw, and I. D. Pavord, “Comparison of airway immunopathology of eosinophilic bronchitis and asthma,” Thorax, vol. 58, no. 6, pp. 528–532, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. W. S. Alexander and D. J. Hilton, “The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response,” Annual Review of Immunology, vol. 22, pp. 503–529, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. N. A. Barrett and K. F. Austen, “Innate cells and T helper 2 cell immunity in airway inflammation,” Immunity, vol. 31, no. 3, pp. 425–437, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Elliott and J. A. Johnston, “SOCS: role in inflammation, allergy and homeostasis,” Trends in Immunology, vol. 25, no. 8, pp. 434–440, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Kubo, T. Hanada, and A. Yoshimura, “Suppressors of cytokine signaling and immunity,” Nature Immunology, vol. 4, no. 12, pp. 1169–1176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Fujimoto and T. Naka, “Regulation of cytokine signaling by SOCS family molecules,” Trends in Immunology, vol. 24, no. 12, pp. 659–666, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. C. R. Yu, R. M. Mahdi, S. Ebong, B. P. Vistica, I. Gery, and C. E. Egwuagu, “Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells,” Journal of Biological Chemistry, vol. 278, no. 32, pp. 29752–29759, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Banerjee, A. S. Banks, M. C. Nawijn, X. P. Chen, and P. B. Rothman, “Cutting edge: suppressor of cytokine signaling 3 inhibits activation of NFATp,” Journal of Immunology, vol. 168, no. 9, pp. 4277–4281, 2002. View at Google Scholar · View at Scopus
  12. A. Matsumoto, Y. I. Seki, R. Watanabe et al., “A role of suppressor of cytokine signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated interleukin 2 production,” Journal of Experimental Medicine, vol. 197, no. 4, pp. 425–436, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Yoshimura, T. Naka, and M. Kubo, “SOCS proteins, cytokine signalling and immune regulation,” Nature Reviews Immunology, vol. 7, no. 6, pp. 454–465, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Churchill, F. H. Chilton, J. H. Resau, R. Bascom, W. C. Hubbard, and D. Proud, “Cyclo-oxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells,” American Review of Respiratory Disease, vol. 140, no. 2, pp. 449–459, 1989. View at Google Scholar · View at Scopus
  15. F. Delamere, E. Holland, S. Patel, J. Bennett, I. Pavord, and A. Knox, “Production of PGE2 by bovine cultured airway smooth muscle cells and its inhibition by cyclo-oxygenase inhibitors,” British Journal of Pharmacology, vol. 111, no. 4, pp. 983–988, 1994. View at Google Scholar · View at Scopus
  16. E. Melillo, K. L. Woolley, P. J. Manning, R. M. Watson, and P. M. O'Byrne, “Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects,” American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 5, pp. 1138–1141, 1994. View at Google Scholar · View at Scopus
  17. I. D. Pavord, C. S. Wong, J. Williams, and A. E. Tattersfield, “Effect of inhaled prostaglandin E2 on allergen-induced asthma,” American Review of Respiratory Disease, vol. 148, no. 1, pp. 87–90, 1993. View at Google Scholar · View at Scopus
  18. P. J. Manning, C. G. Lane, and P. M. O'Byrne, “The effect of oral prostaglandin E1 on airway responsiveness in asthmatic subjects,” Pulmonary Pharmacology, vol. 2, no. 3, pp. 121–124, 1989. View at Google Scholar · View at Scopus
  19. J. D. Curlewis, S. P. Tam, P. Lau et al., “A prostaglandin F2α analog induces suppressors of cytokine signalling-3 expression in the corpus luteum of the pregnant rat: a potential new mechanism in luteolysis,” Endocrinology, vol. 143, no. 10, pp. 3984–3993, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Cheon, Y. H. Rho, S. J. Choi et al., “Prostaglandin E2 augments IL-10 signaling and function,” Journal of Immunology, vol. 177, no. 2, pp. 1092–1100, 2006. View at Google Scholar · View at Scopus
  21. A. K. Boer, A. L. Drayer, H. Rui, and E. Vellenga, “Prostaglandin-E2 enhances EPO-mediated STAT5 transcriptional activity by serine phosphorylation of CREB,” Blood, vol. 100, no. 2, pp. 467–473, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Sastre, M. Fernández-Nieto, R. Mollá et al., “Increased prostaglandin E2 levels in the airway of patients with eosinophilic bronchitis,” Allergy, vol. 63, no. 1, pp. 58–66, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. American Thoracic Society, “Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma,” American Review of Respiratory Research, vol. 136, no. 1, pp. 225–244, 1987. View at Google Scholar
  24. Global Strategy for Asthma Management and Prevention, NIH Publication no. 02-3659, GINA, 2002, Update from NHLB/WHO Workshop Report 1995.
  25. M. M. Bradford, “A rapid and sensitive method for quantisation of micrograms quantities of protein utilizing the principle of protein-dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar · View at Scopus
  26. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Menegazzi, G. Zabucchi, A. Knowles, R. Cramer, and P. Patriarca, “A new, one-step assay on whole cell suspension for peroxidase secrection by human neutrophils asn eosinophils,” Journal of Leukocyte Biology, vol. 52, no. 6, pp. 619–624, 1992. View at Google Scholar · View at Scopus
  28. Y. I. Seki, K. Hayashi, A. Matsumoto et al., “Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 20, pp. 13003–13008, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. C. E. Egwuagu, C. R. Yu, M. Zhang, R. M. Mahdi, S. J. Kim, and I. Gery, “Suppression of cytokine signaling proteins are differentially expressed in TH1 and TH2 cells: implications for TH cell lineage commitment and maintenance,” Journal of Immunology, vol. 168, no. 7, pp. 3181–3187, 2002. View at Google Scholar · View at Scopus
  30. H. Qin, K. L. Roberts, S. A. Niyongere, Y. Cong, C. O. Elson, and E. N. Benveniste, “Molecular mechanism of lipopolysaccharide-induced SOCS-3 gene expression in macrophages and microglia,” Journal of Immunology, vol. 179, no. 9, pp. 5966–5976, 2007. View at Google Scholar · View at Scopus
  31. S. Fukuyama, T. Nakano, T. Matsumoto et al., “Pulmonary suppressor of cytokine signaling-1 induced by IL-13 regulates allergic asthma phenotype,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 11, pp. 992–998, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. I. Seki, H. Inoue, N. Nagata et al., “SOCS-3 regulates onset and maintenance of Th2 mediated allergic responses,” Nature Medicine, vol. 9, no. 8, pp. 1047–1054, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. N. M. Heller, S. Matsukura, S. N. Georas et al., “Interferon-γ inhibits STAT6 signal transduction and gene expression in human airway epithelial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 31, no. 5, pp. 573–582, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Arakawa, Y. Hatano, and K. Katagiri, “Differential expression of mRNA for Th1 and Th2 cytokine-associated transcription factors as suppressors of cytokine signaling in peripheral blood mononuclear cells of patients with atopic dermatitis,” Clinical and Experimental Immunology, vol. 135, no. 3, pp. 505–510, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Kubo and H. Inoue, “Suppressor of cytokine signaling 3 (SOCS-3) in Th2 cells evokes Th2 cytokines, IgE and eosinophilia,” Current Allergy and Asthma Reports, vol. 6, no. 1, pp. 32–39, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. J. L. Barclay, S. T. Anderson, M. J. Waters, and J. D. Curlewis, “Characterization of the SOCS3 Promoter Response to Prostaglandin E2 in T47D Cells,” Molecular Endocrinology, vol. 21, no. 10, pp. 2516–2528, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Hebenstreit, P. Luft, A. Schmiedlechner, A. Duschl, and J. Horejs-Hoeck, “SOCS-1 and SOCS-3 inhibit IL-4 and IL-13 induced activation of Eotaxina-3/CCL26 gene expression in HEK293 cells,” Molecular Immunology, vol. 42, no. 3, pp. 295–303, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. E. M. Sturm, P. Schratl, R. Schuligoi et al., “Prostaglandin E2 inhibits eosinophil trafficking through E-prostanoid 2 receptors,” Journal of Immunology, vol. 181, no. 10, pp. 7273–7283, 2008. View at Google Scholar · View at Scopus
  39. S. Ying, B. J. O'Connor, Q. Meng et al., “Expression of prostaglandin E2 receptor subtypes on cells in sputum from patients with asthma and controls: effect of allergen inhalation challenge,” Journal of Allergy and Clinical Immunology, vol. 114, no. 6, pp. 1309–1316, 2004. View at Publisher · View at Google Scholar · View at Scopus